Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma

Mejia Saldarriaga, M., Pan, D., Unkenholz, C., Mouhieddine, T. H., Velez-Hernandez, J. E., Engles, K., Fein, J. A., Monge, J., Rosenbaum, C., Pearse, R., Jayabalan, D., Gordillo, C., Chan, H. T., Yamshon, S., Thibaud, S., Mapara, M., Inghirami, G., Lentzsch, S., Reshef, R., … Bustoros, M. (2024). Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma. Blood Advances, 8(15), 3859–3869. https://doi.org/10.1182/bloodadvances.2023012470
Authors:
Mateo Mejia Saldarriaga
Caitlin Unkenholz
Juan Esteban Velez-Hernandez
Joshua A. Fein
Jorge Monge
Cara Rosenbaum
Roger Pearse
David Jayabalan
Samuel Yamshon
Ruben Niesvizky
Mark Bustoros
Darren Pan
Tarek H. Mouhieddine
Katherine Engles
Santiago Thibaud
Adriana Rossi
Samir Parekh
Sundar Jagannath
Shambavi Richard
Christian Gordillo
Hei Ton Chan
Markus Mapara
Suzanne Lentzsch
Ran Reshef
Giorgio Inghirami
Affiliated Authors:
Christian Gordillo
Hei Ton Chan
Markus Mapara
Suzanne Lentzsch
Ran Reshef
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2023012470
PMID:
Journal:
Publication Date:
Data Source:
Web of Science

Record Created: